Thermo Fisher Scientific
TMO
1,347 hedge funds and large institutions have $86.9B invested in Thermo Fisher Scientific in 2018 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 441 increasing their positions, 568 reducing their positions, and 63 closing their positions.
49% more first-time investments, than exits
New positions opened: 94 | Existing positions closed: 63
19% more funds holding in top 10
Funds holding in top 10: 99 → 118 (+19)
2% more funds holding
Funds holding: 1,320 → 1,347 (+27)
3% more capital inflows, than outflows
Capital inflows: $3.89B | Capital outflows: $3.78B
0.75% more ownership
Funds ownership: 87.52% → 88.27% (+0.75%)
9% less call options, than puts
Call options by funds: $282M | Put options by funds: $310M
22% less repeat investments, than reductions
Existing positions increased: 441 | Existing positions reduced: 568
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$588M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$571M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$234M |
| 4 |
Fred Alger Management
New York
|
+$213M |
| 5 |
State Street
Boston,
Massachusetts
|
+$174M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$626M |
| 2 |
Longview Partners
St Peter Port,
Guernsey
|
-$393M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$349M |
| 4 |
First Pacific Advisors
El Segundo,
California
|
-$242M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$139M |
TMO Hedge Fund Activity: Q3 2018 in Review
1,347 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2018, worth a combined $86.9B — up 19% from $72.9B a quarter earlier.
Buyers outnumbered sellers: 94 funds opened new TMO positions and 63 closed out — a net gain of 31 holders — while 441 added to existing stakes and 568 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $588M. The largest seller was Capital Research Global Investors, cutting an estimated $626M.
- 1,347 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2018, up from 1,320 in Q2 2018.
- Funds reported $86.9B of Thermo Fisher Scientific stock for Q3 2018, up 19% quarter-over-quarter.
- 94 funds opened new Thermo Fisher Scientific positions in Q3 2018 and 63 closed out, a net change of +31 holders.
- The largest Thermo Fisher Scientific buyer in Q3 2018 was T. Rowe Price Associates, an estimated $588M added.
- The largest Thermo Fisher Scientific seller in Q3 2018 was Capital Research Global Investors, an estimated $626M sold.
Based on aggregated 13F filings for Q3 2018.